HCAT icon

Health Catalyst

3.13 USD
-0.11
3.4%
At close Updated Sep 12, 4:00 PM EDT
Pre-market
After hours
3.13
0.00
0%
1 day
-3.4%
5 days
-7.4%
1 month
4.33%
3 months
-21.36%
6 months
-29.35%
Year to date
-57.36%
1 year
-60.97%
5 years
-91.33%
10 years
-92.01%
 

About: Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platforms, analytics applications, and support services. This generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.

Employees: 1,500

0
Funds holding %
of 7,462 funds
0
Analysts bullish %
of 7 analysts

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

22% more repeat investments, than reductions

Existing positions increased: 55 | Existing positions reduced: 45

2.08% more ownership

Funds ownership: 75.74% [Q1] → 77.82% (+2.08%) [Q2]

0% more funds holding in top 10

Funds holding in top 10: 3 [Q1] → 3 (+0) [Q2]

12% less funds holding

Funds holding: 164 [Q1] → 145 (-19) [Q2]

15% less capital invested

Capital invested by funds: $241M [Q1] → $204M (-$36.7M) [Q2]

50% less call options, than puts

Call options by funds: $302K | Put options by funds: $609K

52% less first-time investments, than exits

New positions opened: 15 | Existing positions closed: 31

Research analyst outlook

7 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$3.5
12% upside
Avg. target
$4.43
41% upside
High target
$6
92% upside

7 analyst ratings

positive
29%
neutral
71%
negative
0%
Canaccord Genuity
Richard Close
$5
Buy
Maintained
29 Aug 2025
Evercore ISI Group
Elizabeth Anderson
$4
In-Line
Maintained
28 Aug 2025
Piper Sandler
Jessica Tassan
$4
Neutral
Downgraded
27 Aug 2025
Wells Fargo
Stan Berenshteyn
$6
Overweight
Maintained
11 Aug 2025
Citigroup
Daniel Grosslight
$3.5
Neutral
Downgraded
8 Aug 2025

Financial journalist opinion

Based on 5 articles about HCAT published over the past 30 days

Neutral
PRNewsWire
3 days ago
Health Catalyst Appoints Ben Albert to the Role of President and COO
Albert Appointed to Drive Health Catalyst Forward in Its Next Chapter of Enabling Measurable Healthcare Improvement SALT LAKE CITY , Sept. 10, 2025 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Ben Albert has been appointed as President and Chief Operating Officer.
Health Catalyst Appoints Ben Albert to the Role of President and COO
Neutral
PRNewsWire
5 days ago
CyncHealth Nebraska Expands Partnership with Health Catalyst to Accelerate Measurable Improvement in Nebraska
SALT LAKE CITY , Sept. 9, 2025 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced a new partnership with CyncHealth Nebraska, the statewide health information exchange (HIE).
CyncHealth Nebraska Expands Partnership with Health Catalyst to Accelerate Measurable Improvement in Nebraska
Neutral
PRNewsWire
15 days ago
Health Catalyst Announces Winners of the 2025 Catalyst Awards
Recognizing Healthcare's Data-Driven Innovators at the 2025 Health Catalyst Analytics Summit SALT LAKE CITY , Aug. 29, 2025 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced the winners of the 2025 Catalyst Awards, an annual program recognizing healthcare organizations at the forefront of data-driven transformation.   The Catalyst Awards were presented at the Health Catalyst Analytics Summit (HAS) 2025 in Salt Lake City, Utah.
Health Catalyst Announces Winners of the 2025 Catalyst Awards
Neutral
PRNewsWire
19 days ago
Health Catalyst Announces Upfront: Market Insights on Salesforce AppExchange
Hospitals and Health Systems Can Now Benefit from a Validated Consumer Science Model and Proprietary Business Intelligence SALT LAKE CITY , Aug. 26, 2025 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Upfront by Health Catalyst ("Upfront") has launched Market Insights on Salesforce AppExchange, a leading enterprise marketplace for partner apps and experts. With Market Insights, clients can guide more patients to care using actionable consumer insights that drive content optimizations, power intelligent user journeys, and improve campaign performance.
Health Catalyst Announces Upfront: Market Insights on Salesforce AppExchange
Neutral
GlobeNewsWire
23 days ago
Health Catalyst to Participate in Upcoming Investor Conferences
SALT LAKE CITY, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that members of senior management will participate in the following upcoming investor conferences:
Health Catalyst to Participate in Upcoming Investor Conferences
Neutral
Seeking Alpha
1 month ago
Health Catalyst, Inc. (HCAT) Q2 2025 Earnings Call Transcript
Health Catalyst, Inc. (NASDAQ:HCAT ) Q2 2025 Earnings Conference Call August 7, 2025 5:00 PM ET Company Participants Daniel LeSueur - Chief Operating Officer Daniel D. Burton - CEO & Director Jack Knight - Corporate Participant Jason Alger - Chief Financial Officer Conference Call Participants Daniel R.
Health Catalyst, Inc. (HCAT) Q2 2025 Earnings Call Transcript
Positive
Zacks Investment Research
1 month ago
Compared to Estimates, Health Catalyst (HCAT) Q2 Earnings: A Look at Key Metrics
The headline numbers for Health Catalyst (HCAT) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Compared to Estimates, Health Catalyst (HCAT) Q2 Earnings: A Look at Key Metrics
Positive
Zacks Investment Research
1 month ago
Health Catalyst (HCAT) Q2 Earnings and Revenues Beat Estimates
Health Catalyst (HCAT) came out with quarterly earnings of $0.04 per share, beating the Zacks Consensus Estimate of $0.03 per share. This compares to earnings of $0.12 per share a year ago.
Health Catalyst (HCAT) Q2 Earnings and Revenues Beat Estimates
Neutral
PRNewsWire
1 month ago
Health Catalyst Announces CEO Dan Burton to Step Down to Pursue Service Opportunities
Mr. Burton to Retire June 30, 2026, Actively Committed to Support Board in Transition and New CEO Search SALT LAKE CITY , Aug. 7, 2025 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Health Catalyst Chief Executive Officer Dan Burton is stepping down from his role as CEO, effective June 2026, to enable additional time to pursue a few volunteer service opportunities he and his wife will participate in, in support of their faith, as active members of the Church of Jesus Christ of Latter-Day Saints. As a result, Mr.
Health Catalyst Announces CEO Dan Burton to Step Down to Pursue Service Opportunities
Neutral
GlobeNewsWire
1 month ago
Health Catalyst Reports Second Quarter 2025 Results
SALT LAKE CITY, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (“Health Catalyst,” Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter ended June 30, 2025. “For the second quarter of 2025, I am pleased by our strong financial results, including total revenue of $80.7 million and Adjusted EBITDA of $9.3 million, with these results beating our quarterly guidance on each metric.
Health Catalyst Reports Second Quarter 2025 Results
Charts implemented using Lightweight Charts™